Skip to main content
Equibles

Rehmann Capital Advisory Group

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1633037 LANSING, MI
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 20, 2026
Position Value
$1,129,854
-$719,073 QoQ
Shares Held
1,812
-24.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#624
of 1,329 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rehmann Capital Advisory Group holds $2,257,367 across 4 Biotechnology names. REGN ranks #1 (50.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page 		1,812 $1,129,854
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,846 $916,963
3 ARGX
Argenx SE
 220 $204,109
4 JSPR
Jasper Therapeutics, Inc.
 15,300 $6,441

All Filings in REGN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,129,854 1,812
2026-03-31 $1,848,927 2,393
2025-12-31 $1,830,103 2,371
2025-09-30 $1,207,755 2,148
2025-06-30 $883,575 1,683
2025-03-31 $920,901 1,452
2024-12-31 $485,809 682
2024-09-30 $565,567 538
2024-06-30 $663,199 631
2024-03-31 $578,456 601
2023-12-31 $461,102 525
2023-09-30 $397,489 483
2023-06-30 $332,684 463
2023-03-31 $369,751 450
2022-12-31 $288,596 400
2022-09-30 $318,946 463
2022-06-30 $268,964 455
2022-03-31 $695,626 996
2021-12-31 $598,049 947
2021-09-30 $546,477 903
2021-06-30 $487,046 872
2021-03-31 $471,247 996
2020-12-31 $442,045 915